Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 14, 2023 | N8 MEDICAL RECEIVES INVIMA APPROVAL TO COMMERCIALIZE ITS CERASHIELD ENDOTRACHEAL TUBE IN COLOMBIA | Biofilm-resistant endotracheal tube Designed to reduce ventilator associated respiratory infections (VARI) and significantly lower overall cost of care INVIMA grants N8 Medical authorization for importation and sale of CeraShield ETT for us... |
Reviews 0
FAQ about INVIMA
What has the press written about INVIMA?
Parsers VC has collected 2 articles mentioning INVIMA, among them “N8 MEDICAL RECEIVES INVIMA APPROVAL TO COMMERCIALIZE ITS CERASHIELD ENDOTRACHEAL TUBE IN COLOMBIA” (Mar 14, 2023).
Is INVIMA still active?
Yes, INVIMA is active; its latest activity on Parsers VC dates from Aug 13, 2025.